Advertisement Lantheus signs manufacturing agreement with JHS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lantheus signs manufacturing agreement with JHS

Lantheus Medical Imaging has signed new manufacturing and supply agreements with Jubilant HollisterStier (JHS) for Cardiolite and Neurolite.

JHS will manufacture Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) products and Neurolite (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) under separate agreements.

Each five year agreement has an option to renew for an additional five years thereafter.

Lantheus Medical Imaging manufacturing and supply chain vice president Bill Dawes said, "We are in the final stages of completing technology transfer for DEFINITY® and will be working closely with the company to expedite similar processes for the manufacture of Cardiolite® and Neurolite®."

Cardiolite and Neurolite are technetium-based radiopharmaceutical imaging agents used in single-photon emission computed tomography, or SPECT.